# Therapy in Amyotrophic Lateral Sclerosis (TAME)

> **NCT02118727** · PHASE2 · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 89 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis
- Frontal Temporal Dementia

## Interventions

- **DRUG:** Memantine
- **DRUG:** Placebo (for Memantine)

## Key facts

- **NCT ID:** NCT02118727
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-07
- **Primary completion:** 2021-07-22
- **Final completion:** 2021-07-22
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2022-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02118727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02118727, "Therapy in Amyotrophic Lateral Sclerosis (TAME)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02118727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*